All News

In an analysis of data from 2 patient cohorts included in the phase 2 BYLieve study, investigators found that the data may indicate an increased dependence on the mutant PI3K-α.

Results from a phase 3b study showed that venetoclax combined with azacitidine or decitabine can safely be initiated in a US community-based outpatient setting.

Renin-angiotensin-aldosterone system inhibitors found to reduce the risk of an aneurysm rupture by 18%.

Tolvaptan (Jynarque )is a selective vasopressin V2-receptor antagonist .

IBS Complete Support helps relieve abdominal pain, bloating, and constipation associated with irritable bowel syndrome.

Ciprodex is approved for the treatment of ear infections, acute otitis media, and acute otitis externa.

Medication adherence is critical to control the symptoms of congestive heart failure.

Pharmacists as immunizers are vaccine distributors, educators, facilitators, and administrators.

Blinded independent central review analysis also adds confidence to the findings.

The American Society of Health-System Pharmacists’ conference includes educational opportunities that feature the latest products, services, and technology in the industry.

JZP458, a recombinant Erwinia-derived ASNase from a Pseudomonas fluorescens expression platform, was previously approved by the FDA for patients with ALL/LBL who had developed hypersensitivity to Escherichia coli (E. coli)–derived ASNase.

Abrons’ work with global underserved care extends to multiple countries; however, her primary work centers around partnerships in Dominica, collaborating with a local eco-based, social entrepreneur, the Ministry of Health, and a private pharmacy.

Citalopram (Celexa) is indicated for the treatment of major depressive disorder in adults.

Pepcid is indicated in adult and pediatric patients 40 kg and above for the treatment of active duodenal ulcer active gastric ulcer.

Investigators reported that individuals who completed 10 cycles of lurbinectedin and doxorubicin who then switched to lurbinectedin as a monotherapy tended to have maintained or improved tumor response.

Investigators found that individuals receiving selinexor had a median PFS of 5.7 months compared to 3.8 months for those given the placebo, with a stratification adjusted hazard ratio of 0.70.

In clinical trials, Xiidra was found to improve eye dryness scores significantly compared with placebo.

The ability to measure GFR would be a significant advancement for clinicians in the United States.

Dosing recommendations for patients requiring ECMO support are unlikely to be supported by high-quality evidence, but are usually extrapolated from the physicochemical characteristics of individual drugs in conjunction with data from pharmacokinetic studies and case reports.

The FDA Vaccines and Related Biological Products Advisory Committee voted nearly unanimously for an emergency use authorization for the Novavax COVID-19 vaccine, NVX-CoV2373, for use in individuals 18 years of age and older.

Scot Ebbinghaus, MD, vice president of oncology clinical research at Merck, discussed the growing body of research surrounding pembrolizumab (Keytruda) and what it is currently being investigated for.

Mentorship in pharmacy is particularly important because it may contribute to the development of competent, proficient, and motivated pharmacists to lead the profession and continue to advance the field.

Additionally, the 2-time dependent variables, dose reduction, and relative dose intensity 2 (RDI2) were included in the respective model as covariates to explore the connection to overall survival.

Approval in this patient population makes dupilumab the first and only biologic medicine approved for the treatment of moderate-to-severe atopic dermatitis from infancy through adulthood.

Cymbalta is a serotonin and norepinephrine reuptake inhibitor indicated for major depressive disorder and anxiety, diabetic peripheral neuropathy, fibromyalgia, and chronic pain related to the muscles and bones.

Gastro-Ease helps maintain a healthy stomach, promoting health and comfort.

Overall, the investigators observed that the CR, undetectable minimal residual disease rates, progression free survival, and overall survival amomg the patients enrolled in the trial were favorable.

Ginna Laport, MD, discussed the growing body of research surrounding venetoclax.